What You Should Know
- Axena Health has announced a major expansion of its collaboration with Mayo Clinic to develop a new, AI-integrated solution for women with pelvic floor disorders.
- Building on their initial 2025 partnership, the new initiative aims to leverage Mayo Clinic’s clinical expertise to create personalized care pathways that improve treatment adherence for conditions like urinary incontinence and overactive bladder (OAB).
Solving the Adherence Gap: AI as a Clinical
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
The Future of Pharmacovigilance: How Agentic AI and Automation Are Redefining Drug Safety
For decades, drug safety has depended on one simple but demanding task: turning fragments of information from patients, physicians, and trials into clear signals that protect lives. Today, that responsibility sits at the center of a digital revolution. Artificial intelligence and automation are transforming pharmacovigilance from a manual, reactive discipline into one that is fast, predictive, and globally connected. The change is cultural, reshaping how safety professionals think, collaborate,
Read More
The Autonomous Revenue Cycle: Waystar Launches Agentic AI to Prevent Billions in Denials
What You Should Know
- Healthcare payment provider Waystar has announced the introduction of agentic intelligence to its cloud-native platform, marking a pivotal step toward the industry's first autonomous revenue cycle.
- Powered by the Waystar AltitudeAI™ engine and a dataset comprising 7.5 billion annual transactions, the new agentic network is designed to execute defined tasks and learn from outcomes with minimal intervention, significantly reducing administrative friction for
Read More
Converge Bio Lands $25M to Replace Trial-and-Error Drug Discovery
What You Should Know
- Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
- Moving beyond the "AI promise" gap, the company provides end-to-end AI systems that plug directly into existing drug development workflows, already serving over a dozen pharmaceutical and biotech customers to optimize target discovery and protein manufacturing.
The Systemic Pivot: Bridging the Gap Between Promise and Reality
While
Read More
Xella Health Raises $3.7M to Pioneer AI-Powered Menstrual Fluid Diagnostics
What You Should Know
- Xella Health has emerged from stealth with $3.7M in pre-seed financing to build the infrastructure for "decoding" female biology.
- Led by Precursor Ventures, the company is pioneering a first-of-its-kind diagnostic platform that combines menstrual fluid analysis with peripheral blood and AI-powered multi-omics to identify the root causes of chronic conditions like endometriosis, PCOS, and perimenopause.
The Biological Signal: Tapping Into Menstrual
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences
What You Should Know
- Anthropic has officially launched Claude for Healthcare, a suite of HIPAA-ready tools that allow providers and payers to use its latest model, Opus 4.5, for high-stakes medical tasks like prior authorization and claims appeals.
- Simultaneously, the company has significantly expanded Claude for Life Sciences, adding deep integrations with platforms like Medidata and ClinicalTrials.gov to automate clinical trial operations and regulatory submissions.
The Engine:
Read More
Allos AI Raises $5M to Reformulate Complex Drugs with Glass-Box Causal AI
What You Should Know
- Allos AI has emerged from stealth with $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry’s first “glass-box” Causal AI platform.
- Unlike traditional AI that focuses on discovering new molecules, Allos targets the "formulation gap"—applying causal modeling to existing complex generics and next-generation medicines to improve their tolerability, bioavailability, and long-term patient outcomes.
The Problem: The
Read More
Penguin Ai Launches Snowflake Native App to Automate HCC Risk Adjustment
What You Should Know
- Penguin Ai has announced the launch of its Hierarchical Condition Category (HCC) Coding & Risk Adjustment solution as a Snowflake Native App.
- By bringing its risk-adjustment intelligence directly into a customer’s Snowflake environment, Penguin Ai enables Medicare Advantage (MA) plans and risk-bearing providers to automate diagnosis extraction and improve Risk-Adjustment Factor (RAF) accuracy without moving or exposing sensitive patient data.
The "Data
Read More
HealthEx and Anthropic Partner to Bring Personal Health Records Directly to Claude
What You Should Know
- HealthEx and Anthropic have launched a first-of-its-kind integration that allows Claude Pro and Max users to securely connect their medical records from over 50,000 provider organizations directly to the AI.
- The partnership leverages the federal TEFCA framework and a new Model Context Protocol (MCP) to provide personalized health summaries and lab interpretations while ensuring that sensitive patient data is never used for model training.
Bridging the
Read More
